Newbury Pharmaceuticals AB Stock: price and insider trades · Sweden
No insider purchase over the last 90 days. The latest, by Alsakali Equity AB, was filed 18 Nov 2025.
Newbury Pharmaceuticals AB: what insiders have been doing
Newbury Pharmaceuticals AB belongs to the Health Care sector. Filings by its managers are published through Finansinspektionen. The last twelve months, up to 29 October 2026, brought 3 filings signed by 1 insider.
Not one open-market sale was filed. On the buying side, 1 insider reported 3 purchases totalling €16k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The buyers include 1 chief executive. The largest single trade was a purchase of €8,588 by Alsakali Equity AB, published on 17 November 2025, equal to 0.12% of the market capitalisation.
The most recent open-market purchase was published on 18 November 2025, 355 days ago. Publication is fast: at least half of the trades appear on Finansinspektionen on the same day. Under the Market Abuse Regulation, managers have three business days to notify their trades.
Across the 1,031 companies tracked on its exchange, the median is 9 filings; at 3 filings, this issuer sits below that mark. Looking back to 2022, when coverage begins, insiders filed 35 purchases and 6 sales.
In the same sector, recent insider purchases at Dynavox Group AB and EssilorLuxottica also feature in our signals. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
Who traded when
BuySaleSince the insiders bought
- -27.9%Entry SEK 1.54 · Close at T+90 SEK 1.11
- -66.6%Entry SEK 3.52 · Close at T+365 SEK 1.17
- +22.1%Entry SEK 3.08 · Close at T+365 SEK 3.76
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended August 2025 · cache
- 25,859 shares@ SEK 1.590.050% mcap30.3% of flowAktieISIN SE0015244884FI:A003T777-1Canonical exit: 16 Feb 2026 (T+90)
- 67,855 shares@ SEK 1.390.12% mcap69.7% of flowAktieISIN SE0015244884FI:A003T734-1Canonical exit: 15 Feb 2026 (T+90)
- 20,000 shares@ SEK 1.90861.0% of flowAktieISIN SE0015244884FI:csv-8f36828347f38668d12dCanonical exit: 10 Feb 2026 (T+90)
- 5,000 shares@ SEK 3.11419.5% of flowAktieISIN SE0015244884FI:csv-1b231064add6b2dd71b3Canonical exit: 28 Jul 2025 (T+90)
- 10,200 shares@ SEK 3.0218.8% of flowAktieISIN SE0015244884FI:csv-801a380521a038ec57c0Canonical exit: 28 Jul 2025 (T+90)
- 2,436 shares@ SEK 3.014.5% of flowAktieISIN SE0015244884FI:csv-3363ae755fabd42a0cd8
- 13,564 shares@ SEK 3.0024.9% of flowAktieISIN SE0015244884FI:csv-e6252a1f3992bb823358
- 10,400 shares@ SEK 2.9718.9% of flowAktieISIN SE0015244884FI:csv-56683e9c5782611f6cd6
- 100 shares@ SEK 3.050.2% of flowAktieISIN SE0015244884FI:csv-5d5c2f64cb22b904d713
- 5,000 shares@ SEK 3.040.019% mcap100.0% of flowAktieISIN SE0015244884FI:A003N711-1Canonical exit: 28 Jul 2025 (T+90)
- 970 shares@ SEK 3.528.6% of flowAktieISIN SE0015244884FI:csv-65390d3903e572bc21c0Canonical exit: 18 Mar 2025 (T+90)
- 200,000 shares0WarrantFI:csv-03d4902a75cfda4ef415
- 200,000 shares0TeckningsoptionFI:csv-0201c229c55ac274b76e
- 200 shares0WarrantFI:csv-0d949c3a060992481d41
- 200,000 shares0WarrantFI:csv-c79b6d0c005fd9d2eee8
- 200,000 shares@ SEK 0.89100.0% of flowWarrantFI:csv-81dfa3ca2f0e84a2d985
- 200,000 shares0WarrantISIN SE0015244884FI:csv-9a6be32c6694b428a219
- 200,000 shares@ SEK 0.8923.7% of flowWarrantISIN SE0015244884FI:csv-7a45e0175638ac451d47Canonical exit: 1 Nov 2024 (T+90)
- 612,500 shares0AktieISIN SE0015244884FI:csv-3dbd8adb761cbdb4f00d
- 612,500 shares0AktieISIN SE0015244884FI:csv-87d05227bf50f76491c0
- 4,376 shares@ SEK 4.5751.3% of flowAktieISIN SE0015244884FI:csv-3c2e1ad947acb54ac3e2Canonical exit: 15 May 2024 (T+90)
- 7,000 shares@ SEK 4.780.9% of flowAktieISIN SE0015244884FI:csv-4b073604dd0abbfb8e44Canonical exit: 24 Apr 2024 (T+90)
- 4,000 shares@ SEK 4.840.5% of flowAktieISIN SE0015244884FI:csv-091aad5e86893bd166fbCanonical exit: 22 Apr 2024 (T+90)
- 4,000 shares@ SEK 4.730.5% of flowAktieISIN SE0015244884FI:csv-50b1d7bd2ce2f737b64cCanonical exit: 21 Apr 2024 (T+90)
- 6,000 shares@ SEK 3.750.6% of flowAktieISIN SE0015244884FI:csv-e76141a95f128ace57cdCanonical exit: 15 Apr 2024 (T+90)
25 of 54 declarations
About Newbury Pharmaceuticals AB
Newbury Pharmaceuticals AB is a company focused on the health and pharmaceutical sector. It is listed on the Stockholm Stock Exchange (XSTO).
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
